Stay updated on Nivolumab & Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the Nivolumab & Ipilimumab in Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPubMed publication text updated to reflect auto-fill from PubMed and the revision tag updated to v3.3.2. The previous, more detailed PubMed note and revision v3.2.0 were removed.SummaryDifference0.1%

- Check28 days agoChange DetectedDeleted a general funding/operating-status notice; no study content, eligibility criteria, or results were affected.SummaryDifference0.4%

- Check42 days agoChange DetectedThe update appears to be a visual/layout refresh without any changes to the study details like the title, condition, locations, enrollment, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedUpdated the page to v3.2.0 with a new government-funding operating-status notice; removed the old v3.1.0 reference.SummaryDifference4%

- Check78 days agoChange DetectedCore page content updated to a new version label: from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check93 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, indicating a minor patch. The deletion of 'Back to Top' is a small UI change, with no substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.2%

Stay in the know with updates to Nivolumab & Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.